These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26071899)

  • 1. RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment.
    Lefterov I; Schug J; Mounier A; Nam KN; Fitz NF; Koldamova R
    Neurobiol Dis; 2015 Oct; 82():132-140. PubMed ID: 26071899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
    Corona AW; Kodoma N; Casali BT; Landreth GE
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):61-72. PubMed ID: 26175148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RXR controlled regulatory networks identified in mouse brain counteract deleterious effects of Aβ oligomers.
    Nam KN; Mounier A; Fitz NF; Wolfe C; Schug J; Lefterov I; Koldamova R
    Sci Rep; 2016 Apr; 6():24048. PubMed ID: 27051978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury.
    Castranio EL; Mounier A; Wolfe CM; Nam KN; Fitz NF; Letronne F; Schug J; Koldamova R; Lefterov I
    Neurobiol Dis; 2017 Sep; 105():1-14. PubMed ID: 28502803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.
    Cramer PE; Cirrito JR; Wesson DW; Lee CY; Karlo JC; Zinn AE; Casali BT; Restivo JL; Goebel WD; James MJ; Brunden KR; Wilson DA; Landreth GE
    Science; 2012 Mar; 335(6075):1503-6. PubMed ID: 22323736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene.
    Boehm-Cagan A; Michaelson DM
    J Neurosci; 2014 May; 34(21):7293-301. PubMed ID: 24849361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.
    Mounier A; Georgiev D; Nam KN; Fitz NF; Castranio EL; Wolfe CM; Cronican AA; Schug J; Lefterov I; Koldamova R
    J Neurosci; 2015 Aug; 35(34):11862-76. PubMed ID: 26311769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.
    Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G
    J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice.
    LaClair KD; Manaye KF; Lee DL; Allard JS; Savonenko AV; Troncoso JC; Wong PC
    Mol Neurodegener; 2013 Jun; 8():18. PubMed ID: 23764200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
    Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
    J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease.
    Savage JC; Jay T; Goduni E; Quigley C; Mariani MM; Malm T; Ransohoff RM; Lamb BT; Landreth GE
    J Neurosci; 2015 Apr; 35(16):6532-43. PubMed ID: 25904803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.
    Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ
    J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated biology approach reveals molecular and pathological interactions among Alzheimer's Aβ42, Tau, TREM2, and TYROBP in Drosophila models.
    Sekiya M; Wang M; Fujisaki N; Sakakibara Y; Quan X; Ehrlich ME; De Jager PL; Bennett DA; Schadt EE; Gandy S; Ando K; Zhang B; Iijima KM
    Genome Med; 2018 Mar; 10(1):26. PubMed ID: 29598827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
    Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood-brain barrier.
    Bachmeier C; Beaulieu-Abdelahad D; Crawford F; Mullan M; Paris D
    J Mol Neurosci; 2013 Feb; 49(2):270-6. PubMed ID: 22890420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
    Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
    Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.
    Lv J; Ma S; Zhang X; Zheng L; Ma Y; Zhao X; Lai W; Shen H; Wang Q; Ji J
    J Proteomics; 2014 Oct; 110():45-58. PubMed ID: 25108202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study.
    Mirza Z; Beg MA
    Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress Response and Apoptotic Pathway Activation.
    Dheer Y; Chitranshi N; Gupta V; Abbasi M; Mirzaei M; You Y; Chung R; Graham SL; Gupta V
    Mol Neurobiol; 2018 Dec; 55(12):9043-9056. PubMed ID: 29637440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
    Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
    Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.